A detailed history of Nbt Bank N A transactions in Biogen Inc. stock. As of the latest transaction made, Nbt Bank N A holds 665 shares of BIIB stock, worth $105,542. This represents 0.01% of its overall portfolio holdings.

Number of Shares
665
Holding current value
$105,542
% of portfolio
0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$189.07 - $236.8 $125,731 - $157,472
665 New
665 $128,000
Q2 2023

Jul 24, 2023

BUY
$275.25 - $318.06 $14,863 - $17,175
54 Added 6.97%
829 $236,000
Q1 2023

May 02, 2023

SELL
$256.56 - $292.34 $33,096 - $37,711
-129 Reduced 14.27%
775 $215,000
Q3 2022

Nov 08, 2022

BUY
$194.69 - $268.46 $175,999 - $242,687
904 New
904 $241,000
Q4 2021

Jan 27, 2022

SELL
$223.92 - $287.77 $202,647 - $260,431
-905 Closed
0 $0
Q3 2021

Oct 18, 2021

SELL
$282.99 - $369.05 $7,074 - $9,226
-25 Reduced 2.69%
905 $256,000
Q1 2021

Apr 08, 2021

BUY
$242.95 - $284.63 $9,718 - $11,385
40 Added 4.49%
930 $260,000
Q4 2020

Jan 15, 2021

BUY
$236.26 - $355.63 $210,271 - $316,510
890 New
890 $218,000
Q2 2020

Jul 22, 2020

SELL
$258.66 - $342.55 $198,909 - $263,420
-769 Closed
0 $0
Q1 2020

Apr 23, 2020

BUY
$268.85 - $341.04 $21,508 - $27,283
80 Added 11.61%
769 $243,000
Q4 2019

Feb 05, 2020

BUY
$220.06 - $304.07 $151,621 - $209,504
689 New
689 $205,000
Q3 2019

Nov 12, 2019

SELL
$217.44 - $243.88 $191,129 - $214,370
-879 Closed
0 $0
Q1 2019

May 06, 2019

SELL
$216.71 - $338.96 $39,007 - $61,012
-180 Reduced 17.0%
879 $208,000
Q4 2018

Feb 14, 2019

SELL
$278.5 - $352.75 $28,964 - $36,686
-104 Reduced 8.94%
1,059 $319,000
Q1 2018

May 22, 2018

SELL
$260.13 - $367.91 $908,373 - $1.28 Million
-3,492 Reduced 75.02%
1,163 $319,000
Q4 2017

Feb 14, 2018

SELL
$307.64 - $344.58 $65,834 - $73,740
-214 Reduced 4.4%
4,655 $1.48 Million
Q3 2017

Nov 07, 2017

BUY
$281.15 - $329.69 $1.14 Million - $1.34 Million
4,050 Added 494.51%
4,869 $1.52 Million
Q2 2017

Aug 08, 2017

BUY
N/A
819
819 $222,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.9B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Nbt Bank N A Portfolio

Follow Nbt Bank N A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nbt Bank N A , based on Form 13F filings with the SEC.

News

Stay updated on Nbt Bank N A with notifications on news.